Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
MedImmune, LLC
Scientific Title
A Phase 1, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Subjects With Advanced Solid Tumors